Ray Kurzweil, the technologist who called the spread of the internet decades early, says ageing could stop being a one-way street within about a decade. Here’s the prediction, and why plenty of scientists aren’t buying it.
The claim isn’t new, but a clip of Kurzweil making it went around the world this month. His forecast: that humanity will reach something called “longevity escape velocity” by around 2032, and that artificial intelligence is what gets us there.
Who is Ray Kurzweil?
If the name’s unfamiliar, Kurzweil is one of the best-known technology forecasters alive. In the 1970s and 80s he built the first reading machine for the blind and pioneering music synthesisers. He’s worked on AI at Google since 2012, and he’s spent decades making long-range predictions, including the rise of the internet and the day a computer would beat the world’s best chess players. He’s now 78, and has been open that he intends to live long enough to benefit from the very technologies he forecasts.
What “longevity escape velocity” means
It sounds like science fiction, but the idea is simple numbers. Today, for every year you live, medicine adds back only a few months of life expectancy. You’re still losing ground. “Escape velocity” is the moment that maths flips, when medicine starts adding a full year or more of life expectancy for every year that passes.
From that point, on paper, the finish line recedes faster than you walk towards it. It isn’t immortality, and it isn’t a promise you’ll feel 25 forever. It’s the narrower claim that death from old age could stop being inevitable. The phrase is borrowed from rocketry, where escape velocity is the speed needed to break free of gravity.
In his 2024 book, Kurzweil wrote that “by around 2030, the most diligent and informed people will reach ‘longevity escape velocity'”, and that “by the end of the 2030s we will largely be able to overcome diseases and the aging process”. In interviews this year he has pinned the tipping point at 2032.
Why he thinks AI changes the maths
Kurzweil’s case rests on speed. He argues AI is starting to design drugs and run “biological simulators” that can generate safety and effectiveness data “in hours rather than the years that clinical trials typically require”. Compress the research, he says, and breakthroughs that today arrive once a decade start arriving far more often.
Why plenty of scientists aren’t convinced
Extending a healthy life is not the same as abolishing ageing, and that’s where the pushback lands. Gerontologist S. Jay Olshansky, who argues dramatic life extension this century is implausible, is the standing skeptic. Even researchers who share Kurzweil’s optimism give later, hedged dates: longevity campaigner Aubrey de Grey puts the odds at about even by the mid-to-late 2030s, and geneticist George Church has floated 2050.
There’s also Kurzweil’s own record. His hits cluster in computing, while his predictions about biology and medicine have tended to run early. This one sits squarely in the second category.
Is there anything to invest in?
The longevity industry is real and well-funded, with industry estimates putting investment at around US$8.5 billion in 2024. The catch for ordinary investors is that the marquee names are mostly private. Altos Labs has raised around US$3 billion, with Jeff Bezos among its backers; Calico is owned by Google parent Alphabet; and Retro Biosciences is tied to ChatGPT-maker OpenAI. Direct, listed exposure is thin.
The next test is Kurzweil’s own timeline. By his reckoning, the first people reach escape velocity within about six years.
